Antiproliferative activity of some tautomeric hydrazones derived from chalcones by Tok, Fatih et al.
Marmara Pharmaceutical Journal 20: 157-163, 2016
DOI: 10.12991/mpj.20162093956
ORIGINAL RESEARCH
157
Antiproliferative activity of some tautomeric hydrazones derived from 
chalcones
Fatih Tok, Nagihan BeyhaN, Bedia kocyigiT-kaymakcioglu
Marmara University, Faculty of Pharmacy, Department of Pharmaceutical 
Chemistry, İstanbul, 34668, Turkey 
yalçın erzurumlu, recep ilhaN, Petek Ballar, 
Ege University, Faculty of Pharmacy, Department of Biochemistry, İzmir, 
35040, Turkey
Address for correspondence: Bedia kocyigiT-kaymakcioglu 
Marmara University, Faculty of Pharmacy, Department of Pharmaceutical 
Chemistry, 34668, Istanbul, Turkey
E-mail: bkaymakcioglu@marmara.edu.tr 
Tel: +90-216-4142963/1023
Fax: +90-216-3452952
Submitted/Gönderilme: 10.03.2016            Revised/Düzeltme: 30.03.2016
Accepted/Kabul: 31.03.2016
Fatih Tok, Nagihan BeyhaN, yalçın erzurumlu, recep ilhaN, Petek Ballar, Bedia kocyigiT-kaymakcioglu
ABSTRACT
a new series of hydrazones synthesized from chalcones. 
Synthesized compounds have been characterized by Ir, 
1h-Nmr and elemental analysis. antiproliferative activity of 
compounds was investigated on hela, a549, mcF7, hcc1937, 
mrc5 cells. all compounds exhibited cytotoxicity. especially 
compounds 1b, 1c, 1f and 1i having 4-metylsulfonyl phenyl 
showed higher cytotoxicity against all of the cell lines compared 
to reference drug doxorubicin with low value of Ic50=5.56-21.93 
µm. The most active compounds 1b, 1c, 1f and 1i were analyzed 
for their effect on autophagic processes. hcc1937 cells were 
treated with these compounds at Ic50 concentration for 24 hours. 
an immunoblotting assay was performed to analysis autophagy 
markers and total polyubiquitinated protein levels. compounds 
1b, 1c, 1f and 1i significantly increased the conversion of lc3-I 
to lc3-II at Ic50 concentration. None of the tested compounds 
changed the level of total polyubiquitinated proteins.
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InTRoDuCTIon
cancer is one of the most important death causes of in the 
world. There are many problems for the control and treatment 
of cancer (1). although numerous cancer treatment methods 
are available, the number of cancer diagnosis increase day 
by day.  Therefore it is aimed to reach effective and selective 
treatment methods for cancer (2). 
chalcones consist of three carbon, α, β-unsaturated carbonyl 
system (3). chalcone nucleus is associated several biological 
activities such as antibacterial, antifungal, antileishmanial, 
anticonvulsant (4), antimalarial, antiviral, anticancer, 
antiinflammatory, antioxidant (5, 6). chalcone derivatives 
are known as xanthine oxidase inhibitors, aldose reductase 
inhibitors, epoxide hydrolase inhibitors, topoisomerase II 
inhibitors and aromatase inhibitors (7). The structure activity 
relationship shows us the presence of double bond with 
conjugation is responsible for the biological activities (8). 
Therefore hydrazone groups are synthesized from chalcones 
with maintaining this structure (9).
There are many studies about cytotoxicity of different 
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chalcone derivatives against cancer cell lines. Won and co-
workers synthesized a new series of chalcones. They searched 
antiinflammatory and anticancer activity of compounds. 
1-(2,5-dimethoxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-
1-one was chosen as  the lead molecule for treatment or 
prevention of mcF-7 cancer cell lines (10).
kumar and co-workers synthesized some α-cyano bis(indolyl)
chalcones and evaluated anticancer activity against three 
different cancer cell lines fluor and methoxy substitution on 
aromatic rings were increased tubulin polymerization (11).
Substitue-4-aryl-4-oxo-butenoic acid amides were 
synthesized by Todorovic et al, and all molecules showed 
antiproliferative activity. It was shown that unsubstitue 
molecule (4-oxo-N,4-diphenylbut-2-enamide) was the most 
potent inhibitor of tubulin (12).
a new series of isoxazolyl chalcones were synthesized and 
screened their activities against h1792, h157, a549 and 
calu-1 cells. 1-(5-methyl-3-(4-nitrophenyl)isoxazol-4-yl)-
3-(2-nitrophenyl)prop-2-en-1-one exhibited significant 
antitumor activity. The result of structure activity relationship 
was showed electron withdrawing group at only 2-position 
on aromatic ring provided more effective molecule than 
others (13).
hydrazones consist of –co-Nh-N=ch- group (14) and 
exhibit different biological activity  such as antifungal (15), 
antimicrobial (16), antitubercular, anticancer (17) depending 
on different substituents. Tautomeric hydrazo groups act 
as donor and acceptor moieties. Therefore it facilitates 
binding to the receptor (18). hydrazone scaffold are very 
important for ph-dependent release of drugs (19). especially 
aroylhydrazide-hydrazone structures bearing hetero-ring 
such as pyridine, pyrazole, oxadiazole, triazole exhibit 
significant anticancer activity. 1-arylmethyl-3-aryl-1h-
pyrazole-5-carbohydrazide hydrazone showed significant 
inhibitory effect against a549 cancer cell lines (20).
according to literature’s data, benzothiazole hydrazones were 
synthesized and their anticancer activity against leukemia, 
breast,  colon cells were evaluated (21). In another study, 
chalconephenyl hydrazones and their cyclized derivatives 
were synthesized and their effect on cathepsin B and h 
were evaluated. Two pharmacologically active group such 
as chalconephenyl hydrazones are beneficial for potential 
antitumor agent’s effect (22).
on the basis of historical backgrounds of the anticancer 
activity of hydrazone derivatives, we synthesized different 
substituted tautomeric hydrazone derivatives and evaluated 
their antiproliferative activity. 
Materials and Methods
Chemistry
Isoniazid was purchased from Sigma-aldrich. The following 
reagent grade chemicals were purchased and used without 
further purification. melting points were determined by 
Schmelzpunktbestimmer SmP II. Ir spectra were recorded 
at Schimadzu FTIr-8400S. 1h-Nmr spectra were recorded 
on a Bruker instrument in DmSo-d6  with TmS as internal 
standard for protons. all the compounds were isolated in 
satisfactory yields (40-65%) and purified by recrystallization 
from ethanol. The purity of the compounds was established 
by thin layer chromatography (Tlc), high Pressure liquid 
chromatography (hPlc) and elemental analysis.
Synthesis of chalcone derivatives
The intermediated chalcones were prepared by reacting 
equimolar aldehyde and ketone in the presence of a 
base by conventional claisen-Schmidt condensation. 
Physicochemical and spectroscopic characterization of the 
chalcones have been previously described (4) . 
General synthesis methods of hydrazone derivatives (1a-1j)
The intermediated chalcones (0.001 mol) were dissolved in 
ethanol and stirred on magnetic stirrer. Then isoniazid (0.001 
mol) was added, the mixture was refluxed at 90-100 oc for 8 
hours. The obtained hydrazones (1a-1j) were filtered, dried 
and crystallized from suitable solvent (23). 
N’-(1-(5-chlorothiophen-2-yl ) -3-phenylal ly lidene)
isonicotinohydrazide (1a)
Pale yellow crystals from ethanol. (%60); m.p. 235-237 ; Ir 
umax..(cm-1): 3375, 3080, 1685, 1560, 1300, 894; 1h-Nmr (400 
mhz), (DmSo-d6/TmS) ppm: 7.20-7.33(d, 2h, -ch=), 8.02-
8.24 (m, 10h, ar-h and Nh). For c19h14clN3oS  (m.W.: 
367.85 g/mol ) calculated: c: 62.04 h: 3.84 N: 11.42. Found: 
c: 62.08 h: 3.81 N: 11.38. 
N’-(1-(5-bromothiophen-2-yl)-3-(2,6-dichlorophenyl)
allylidene)isonicotinohydrazide (1b)
Pale yellow crystals from ethanol. (%45); m.p. 238-239 ; Ir 
umax.(cm-1): 3419, 3377, 3090, 1680, 1599,1315, 1261, 1066, 
856; 1h-Nmr (400 mhz), (DmSo-d6/TmS) ppm: 7.43-
7.45(d, 2h, -ch=), 7.48-7.71(m, 9h, ar-h), 8.05-8.06(s, 1h, 
Nh). For c19h12Brcl2N3oS  (m.W.: 481.19 g/mol ) calculated: 
c: 47.42 h: 2.51 N: 8.73. Found: c: 48.01 h: 2.49 N: 8.72. 
N’-(3-(2,6-dichlorophenyl)-1-(4-(methylsulfonyl)phenyl)
allylidene)isonicotinohydrazide (1c)
Pale yellow crystals from ethanol. (%55); m.p. 245-247 ; 
Ir umax.(cm-1): 3336, 3066, 2974, 2931, 1670, 1573, 1396, 
1259, 1089, 837; 1h-Nmr (400 mhz), (DmSo-d6/TmS) 
ppm:3.25(s, 1h, ch3), 7.42-7.46(d, 2h, -ch=), 7.59-8.25(m, 
12h, ar-h and Nh). For c22h17cl2N3o3S  (m.W.: 474.36 g/
Kocyigit-Kaymakcioglu et al.
Antiproliferative activity of some tautomeric hydrazonesMarmara Pharm J 20: 157-163, 2016 159
mol ) calculated: c: 55.70 h: 3.61 N: 8.86. Found: c: 55.71 h: 
3.65 N: 8.84.
N’-(3-(4-hydroxyphenyl)-1-(thiophen-2-yl)allylidene)
isonicotinohydrazide (1d)
Pale yellow crystals from ethanol. (%45); m.p. 238-240 ; Ir 
umax (cm-1): 3450, 3360, 3085, 1685, 1570, 1378, 845. 1h-Nmr 
(400 mhz), (DmSo-d6/TmS) ppm: 6.80-6.83(d, 2h, -ch=), 
7.25-8.24(m, 12h, ar-h and Nh), 10.3(s, 1h, oh). For 
c19h15N3o2S  (m.W.: 349.41 g/mol ) calculated: c: 65.31 h: 
4.33 N: 12.03. Found: c: 65.30 h: 4.31 N: 12.06. 
N’-(3-(4-methoxyphenyl)-1-(4-(trif luoromethyl)phenyl)
allylidene)isonicotinohydrazide (1e)
Pale yellow crystals from ethanol. (%50); m.p. 232-233 ; Ir 
umax. (cm-1): 3456, 3046, 2937, 2837,1678, 1512, 1319, 1249, 
1066, 831; 1h-Nmr (400 mhz), (DmSo-d6/TmS) ppm: 
3.35(s, 3h, och3), 6.90-6.98(d, 2h, -ch=), 7.34-8.15(m, 
13h, ar-h and Nh). For c23h18F3N3o2  (m.W.: 425.40 g/mol 
) calculated: c: 64.94 h: 4.26 N: 9.88.Found: c: 65.01 h: 4.25 
N: 9.90.
Methyl 4-(3-(2-isonicotinoylhydrazono)-3-(4-(methylsulfonyl)
phenyl)prop-1-enyl)benzoate (1f)
Pale yellow crystals from ethanol. (%55); m.p. 250-252 ; Ir 
umax. (cm-1): 3419, 3010, 2920, 1662, 1309,1215, 1087, 831;  
1h-Nmr (400 mhz), (DmSo-d6/TmS) ppm: 3.32(s, 3h, 
ch3), 3.88(s, 3h, och3), 7.82-7.86(d, 2h,—ch=), 8.02-
8.40(m, 13h, ar-h and Nh). For c24h21N3o5S  (m.W.: 463.51 
g/mol ) calculated: c: 62.19 h: 4.57 N: 9.07. Found: c: 62.04 
h: 4.56 N: 9.08.
Methyl 4-(3-(5-bromothiophen-2-yl)-3-(2-isonicotinoylhydra-
zono)prop-1-enyl)benzoate (1g)
Pale yellow crystals from ethanol. (%54); m.p. 210-212 ; Ir 
umax.(cm-1): 3228, 3093, 3003, 2955, 2847, 1647, 1568, 1315, 
1213, 1076, 846; 1h-Nmr (400 mhz), (DmSo-d6/TmS) 
ppm: 3.88(s, 3h, och3), 7.33-7.45(d, 2h, -ch=), 7.51-
8.26(m, 11h, ar-h and Nh). For c21h16BrN3o3S  (m.W.: 
470.34 g/mol ) calculated: c: 53.63 h: 3.43 N: 8.93. Found: c: 
53.04 h: 3.42 N: 8.91.
N’-(3-(4-(dimethylamino)phenyl)-1-(thiophen-2-yl)
allylidene)isonicotinohydrazide (1h)
Pale red crystals from ethanol. (%57); m.p. 248-250 ; Ir 
umax. (cm-1):3255, 3163, 3084, 2895, 2818, 1629, 1554, 1317, 
1228, 1080, 856; 1h-Nmr (400 mhz), (DmSo-d6/TmS) 
ppm: 3.01(s, 6h, ch3), 6.74-6.76(d, 2h, -ch=), 7.27-8.23(m, 
12h, ar-h and Nh). For c21h20N4oS  (m.W.: 376.47 g/mol 
) calculated: c: 67.00 h: 5.35 N: 14.88. Found: c: 67.04 h: 
5.36 N: 14.90.
N’-(3-(2,6-dichlorophenyl)-1-(thiophen-2-yl)allylidene)
isonicotinohydrazide (1i) 
Pale yellow crystals from ethanol. (%48); m.p. 270-271 ; Ir 
umax..(cm-1): 3219, 3078, 2962, 2816, 1668, 1556, 1356, 1217, 
1045, 869; 1h-Nmr (400 mhz), (DmSo-d6/TmS) ppm: 6.88-
6.96 (d, 2h, -ch=), 7.35-8.33(m, 11h, ar-h and Nh). For 
c19h13cl2N3oS  (m.W.: 402.30 g/mol ) calculated: c: 56.73 h: 
3.26 N: 10.45. Found: c: 56.74 h: 3.25 N: 10.40.
N’-(3-(4-methoxyphenyl)-1-(4-(methylsulfonyl)phenyl)
allylidene)isonicotinohydrazide (1j)
Pale yellow crystals from ethanol. (%52); m.p. 262-263  ; Ir 
umax.(cm-1):3402, 3010, 2928, 2841, 1658, 1566, 1307, 1215, 
1026, 819; 1h-Nmr (400 mhz), (DmSo-d6/TmS) ppm: 
3.31(s, 3h, och3), 3.83(s, 3h, och3), 7.02-7.06(d, 2h, 
-ch=), 7.75-8.35(m, 11h, ar-h and Nh). For c23h21N3o4S  
(m.W.: 435.50 g/mol ) calculated: c: 63.43 h: 4.86 N: 9.65. 
Found: c: 63.64 h: 4.85 N: 9.66.
Anticancer activity
Cell lines and cell culture conditions 
Four cancer cell lines, a549 (human lung cancer cell line), 
hela (human cervical cancer cell line), mcF7 (human 
breast adenocarcinoma cell line), hcc1937 (human breast 
adenocarcinoma cell line with Brca1 mutation) and one 
non-cancer cell line, mrc5 (human fetal lung fibroblast) were 
obtained from aTcc (rockville, mD, uSa).  Dmem (used 
for a549, mcF7, hela), rPmI 1640 (used for hcc1937) 
and emem (used for mrc5) were purchased from lonza 
(Switzerland). all cell culture media were supplemented with 
l-glutamine (2 mmol/l), and 10% fetal bovine serum. cells 
were cultured under 95% air-5% co2 at 37ºc.
Antiproliferative activity assay
The antiproliferative activities of compounds were evaluated 
using WST-1 reagent as previously described (24). Briefly, the 
cells (5.000) were seeded and grown in 96-well plates. after 
24 hours, cells were treated with test compounds at various 
concentrations (30, 15, 10, 7.5, 5μm).  DmSo is used as 
negative solvent control and Doxorubicin is used as positive 
control. The viability of cells was quantitatively assessed by 
WST-1 assay at 48 h post-exposure with test compounds. 
The assay was carried out according to the manufacturer’s 
instructions. Briefly, at the end of 48 h treatment, WST-1 cell 
proliferation reagent (roche applied Sciences, Indianapolis, 
IN, uSa) was added to the cells in 1:10 dilution. Three hours 
after addition of WST-1 reagent, the optical density of each 
well was determined by a spectrophotometric reader at 450 
nm (Versamax, molecular Devices, california, uSa). 690 nm 
wavelength was used as reference.  all measurements were 
performed in triplicates. Ic50 values were calculated using non-
linear curve fitting with graphPad Prism (version 6 graphPad 
Software). all measurements were performed in triplets.
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Immunoblotting
hcc1937 (human breast adenocarcinoma cell line) cells 
were treated with the compounds or DmSo control. 
Immunoblotting studies have been performed as previously 
described (25). cells were lysed in rIPa buffer (150 mm Nacl, 
1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS in 50 
mm Tris-hcl ph 7.5) supplemented with protease inhibitor 
cocktail.  after determining the protein concentration of cell 
lysates using Bca Protein assay kit (PIerce, rockford, 
Il, uSa), equal amounts of proteins were loaded to the 
gels for SDS-Page. Following electrophoresis, proteins 
were transferred to PVDF membrane (millipore, Bedford, 
ma, uSa). Immunoblotting was performed by using lc3 
antibody (cell Signaling, Danvers, massachusetts, uSa), p62 
antibody (cell Signaling, Danvers, massachusetts, uSa), and 
actin antibody (Sigma aldrich, uSa).   For visualization of 
the results, chemiluminescence procedure was performed 
with ecl substrate kit (BioraD, uSa) according to the 
manufacturer’s protocol. The chemiluminescence light was 
captured using Fusion-FX7 imaging system (Vilber lourmat, 
France). Image J software was used for quantification of band 
intensity. n=6 used in these processes. 
Results and Discussion
Chemistry                                                                      
The synthetic route to the target compounds is outlined 
in Scheme 1. The intermediate chalcones were prepared 
by reacting equimolar aldehyde and ketone in presence 
of a base by conventional claisen-Schmidt condensation. 
Physicochemical and spectroscopic characterization of 
the chalcone derivatives have been previously described 
(4). Tautomeric hydrazone derivatives were synthesized 
by the reaction of substituted chalcones and isoniazid. The 
purities of the synthesized compounds were checked by 
reversed phase hPlc (chromasil c18 3.6 x150 mm column 
using acetonitrile and water (50:50 v/v) as the eluent). 
The structures of the hydrazone compounds (1a-j) were 
confirmed by Ir, 1h-Nmr and elemental analysis.  Ir spectra 
of the compounds (1a-j) afforded hydrazone c=N streching 
(1512-1573), N-h streching (3219-3456) and c=o streching 
(1647-1685) bands and aromatic rings c=c streching (1560-
1599), c-h streching (3003-3085) bands. The Nh protons 
of hydrazone groups resonated as a singlet or two different 
singlet peak because of E/Z isomer at 8.24-8.38 ppm. The ch 
protons (methylsulfonyl) appeared as a singlet at 3.35-3.88 
ppm. The ch=ch protons (chalcones) were seen as multiplet 
at 7.25-8.40 ppm with aromatic protons. The elemental 
analysis of hydrazone compounds were in agreement with 
the proposed structures of the compounds.
Scheme 1. Synthetic pathway for targed compounds.
Antiproliferative activity
antiproliferative activity of compounds was investigated on 
four cancer cell lines, a549 (human lung cancer cell line), 
hela (human cervical cancer cell line), mcF7 (human 
breast adenocarcinoma cell line), hcc1937 (human breast 
adenocarcinoma cell line with Brca1 mutation) and one 
non-cancer cell line, mrc5 (human fetal lung fibroblast). 
antiproliferative activity results are presented in Table 1. 
as seen in Table 1, 1a, 1b, 1c, 1f and 1i showed cytotoxicity 
below 30 μm (except a549 of 1a). While 1c is the most 
cytotoxic compound for hela, a549 and mrc5 cells; 1f and 
1i are the most active compounds in mcF7 and hcc1937, 
respectively. The Ic50 values of 1d, 1e, 1g, 1h and 1j could 
not be calculated using tested concentrations (above 30 μm). 
The most active compounds 1b, 1c, 1f and 1i were analyzed 
for their effect on autophagic processes. hcc1937 cells 
were treated with these compounds at Ic50 concentration 
for 24 hours. an immunoblotting assay was performed to 
analysis autophagy markers and total polyubiquitinated 
protein levels. our results show that 1b, 1c, 1f and 1i at 
Ic50 concentration significantly increased the conversion of 
lc3-I to lc3-II. lc3 is a classical autophagosome marker 
and conversion of lc3-I to its lipidated form lc3-II reflects 
maturation autophagosome. Since both autophagy inhibitors 
and inducers may increase the lc3-II/lc3-1 ratio, we 
analyzed the level of p62 protein, which is a known autophagy 
substrate and marker of the stream of the autophagic 
process (26). We noticed that all tested compounds caused 
a significant increase on p62 levels (p<0.005) compared with 
DmSo treated control samples suggesting that autophagy is 
inhibited. Bafilomycin a1, inhibits lysosomal degradation by 
hampering acidification of lysosomes by inhibiting vacuolar 
type h+ aTPase (V-aTPase) (27). as a known autophagy 
inhibitor, Bafilomycin a1 is used as positive control at 100 
ng/ml for 4 hours.
We have also compared the effect of 1b, 1c, 1f and 1i 
on ubiquitin mediated proteasomal degradation. While 
proteasome inhibitor mg132 significantly increased the 
level of total polyubiquitinated proteins, none of the tested 
compounds changed the level of total polyubiquitinated 
proteins compared with DmSo treatment (data not shown). 
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Table 1. Ic50 values (µm) of all compounds.
Comp R1 R2 Hela A549 MCF7 HCC1937 MRC5
1a
S
Cl
ClCl
19.78±0.98 >30 14.39±0.93 14.21±0.27 12.88±0.53
1b
S
Br
ClCl
13.74±0.65 22.58±0.97 10.23±0.62 12.22±0.49 8.45±0.87
1c
S
O
O
ClCl 8.35±0.51 21.93±1.15 19.24±1.93 9.92±0.54 5.56±0.75
1d
S
OH
>30 >30 >30 >30 >30
1e F
F
F
O
>30 >30 >30 >30 >30
1f
S
O
H3C
O
O
O
12.35±0.69 28.6±1.91 7.24±0.47 12.62±0.66 8.45±0.36
1g
S
Br
O
O >30 >30 >30 >30 >30
1h
S
N
>30 >30 >30 >30 >30
1i
S Cl
Cl
11.33±0.81 26.12±1.21 8.75±0.97 9.09±0.76 8.39±0.31
1j
S
O
O
>30 >30 >30 >30 >30
- -
0.87±0.05 1.58±0.08 0.79±0.05 0.68±0.06 0.92±0.03
*reference drug is doxorubicin
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Conclusion
clinical studies have proven anticancer activity of tautomeric 
hydrazone groups. They have also less side effect. Because 
chalcones are not foreign to human body structures of 
chalcone is available in natural product. Therefore chalcones 
which have demonstrated anticancer activity are very 
important for cancer treatment. In this study, we reported 
the synthesis of a new series of hydrazones synthesized from 
chalcones, which were evaluated for their antiproliferative 
activity on on hela, a549, mcF7, hcc1937, mrc5 cells. 
The in vitro assays revealed that all compounds showed 
antiproliferative activity. The replacement of metylsulfonyl 
groups on aromatic rings is beneficial for activity. This study 
may be helpful for finding molecules which are associated 
with cancer treatment.
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